Clinical Trial Update: A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis [EARLY_Phase 1]

View source ↗

Summary

This is a pilot, early-phase 1 clinical trial evaluating granulocyte-macrophage colony-stimulating factor (GM-CSF) in generalized Myasthenia gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Muscular Dystrophy Association | Conditions: Myasthenia Gravis | EARLY_Phase 1 | Status: UNKNOWN